Mural Oncology plc
MURA
$2.08
-$0.01-0.48%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -147.15M | -130.73M | -128.51M | -153.78M | -173.30M |
| Total Depreciation and Amortization | 3.76M | 3.52M | 3.51M | 3.26M | 3.14M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.30M | 721.00K | 2.50M | 16.69M | 19.24M |
| Change in Net Operating Assets | 7.08M | -1.51M | -6.05M | -5.67M | -8.97M |
| Cash from Operations | -130.01M | -128.01M | -128.55M | -139.50M | -159.89M |
| Capital Expenditure | -52.00K | -47.00K | -92.00K | -1.25M | -2.40M |
| Sale of Property, Plant, and Equipment | 847.00K | 67.00K | 67.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 84.50M | 127.18M | -25.31M | -61.48M | -80.80M |
| Cash from Investing | 85.29M | 127.20M | -25.33M | -62.72M | -83.20M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 224.00K | 224.00K | 196.00K | 196.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 315.01M | 366.65M |
| Cash from Financing | 224.00K | 224.00K | 196.00K | 315.21M | 366.65M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -44.49M | -581.00K | -153.68M | 112.99M | 123.56M |